CD79a Immunophenotyping by Flow Cytometry Test
Comprehensive Introduction to CD79a Flow Cytometry
Immunophenotyping by Flow Cytometry CD79a represents a cutting-edge diagnostic approach in modern hematology and oncology. This sophisticated laboratory technique provides invaluable insights into the cellular composition of blood and bone marrow samples, specifically targeting the CD79a antigen – a crucial marker for B-cell lineage identification. As a fundamental component of the B-cell receptor complex, CD79a plays a vital role in B-cell development and function, making its detection essential for accurate diagnosis and classification of various hematological malignancies.
What the CD79a Test Measures and Detects
The CD79a Immunophenotyping test specifically identifies and quantifies the presence of CD79a antigen on cell surfaces using advanced flow cytometry technology. This test provides critical information about:
- B-cell lineage confirmation in suspected hematological malignancies
- Detection of abnormal B-cell populations in blood and bone marrow
- Identification of CD79a expression patterns in various B-cell disorders
- Differentiation between B-cell and T-cell lineage leukemias and lymphomas
- Monitoring minimal residual disease in B-cell malignancies
Who Should Consider CD79a Immunophenotyping
This advanced diagnostic test is particularly important for individuals presenting with symptoms suggestive of hematological disorders, including:
- Unexplained persistent fatigue and weakness
- Recurrent fevers without apparent infection
- Night sweats and unexplained weight loss
- Enlarged lymph nodes that persist for weeks
- Abnormal complete blood count results
- Bone pain or tenderness
- Frequent infections or unusual bleeding
- Patients with suspected or diagnosed B-cell malignancies requiring confirmation
Significant Benefits of CD79a Testing
Choosing CD79a Immunophenotyping by Flow Cytometry offers numerous advantages for patients and healthcare providers:
- Precise Diagnosis: Enables accurate classification of B-cell lineage malignancies
- Treatment Guidance: Provides essential information for targeted therapy selection
- Prognostic Value: Helps determine disease severity and expected outcomes
- Disease Monitoring: Allows tracking of treatment response and disease progression
- Early Detection: Identifies minimal residual disease before clinical relapse
- Comprehensive Analysis: Provides detailed cellular characterization beyond routine testing
Understanding Your CD79a Test Results
Interpreting CD79a immunophenotyping results requires specialized hematological expertise. Generally, results may indicate:
- Positive CD79a Expression: Confirms B-cell lineage in malignant cells, supporting diagnoses like B-cell acute lymphoblastic leukemia or certain lymphomas
- Negative CD79a Expression: May suggest non-B-cell lineage malignancies or specific B-cell maturation stages
- Abnormal Expression Patterns: Can indicate specific subtypes of hematological disorders requiring specialized treatment approaches
- Quantitative Analysis: The percentage and intensity of CD79a expression provide additional diagnostic and prognostic information
Your healthcare provider will discuss your specific results in the context of your clinical presentation and other laboratory findings.
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $88 |
| Regular Price | $112 |
Test Specifications
- Turnaround Time: Sample Daily by 9 am; Report Same day
- Sample Type: 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube AND 3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone marrow in 1 Green Top (Sodium heparin) tube
- Shipping Instructions: Ship immediately at 18-22°C. DO NOT REFRIGERATE OR FREEZE. Specify time, date and clinical details on test request form
- Pre-test Instructions: Provide brief clinical history
Nationwide Availability Across USA
GGC DNA maintains comprehensive laboratory facilities across all major metropolitan areas in the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art flow cytometry departments ensure consistent, high-quality results regardless of collection location.
Book Your CD79a Immunophenotyping Test Today
Take the crucial step toward accurate diagnosis and effective treatment planning. Our specialized team of hematologists and oncologists is ready to provide you with comprehensive care and precise diagnostic results. Contact us now to schedule your CD79a Immunophenotyping by Flow Cytometry test.
Call or WhatsApp: +1(267) 388-9828
Experience the confidence that comes with advanced diagnostic precision from GGC DNA – your trusted partner in comprehensive hematological testing and cancer diagnosis.
